Adicet Bio, Inc. Share Price
NASDAQ: ACET | Micro CapAdicet Bio, Inc. Stock Performance
Adicet Bio, Inc. Share Price Today
As of 29 October 2026, Adicet Bio, Inc.'s share price is $3.83. The stock opened at $3.81, compared to its previous close of $3.77. During today's trading session, Adicet Bio, Inc.'s share price traded between $3.78 and $3.85, with an average price of $3.81. Over the past 52 weeks, the stock has recorded a high of $9.84 and a low of $0.46. In terms of performance, Adicet Bio, Inc.'s share price has declined by 49.24% over the last six months and is up 411.35% on a year-on-year basis.
Adicet Bio, Inc. Share Price Chart
Adicet Bio, Inc. Quarterly Profit & Loss
All figures in USD
Adicet Bio, Inc. Annual Profit & Loss
All figures in USD
About Adicet Bio, Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
Adicet Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $6.84 | $3.83 | -46.69% |
Sep 2026 | $8.90 | $7.18 | -19.54% |
Aug 2026 | $9.10 | $8.93 | -2.08% |
Jul 2026 | $8.91 | $9.12 | +5.68% |
Jun 2026 | $9.17 | $8.63 | -8.00% |
May 2026 | $7.60 | $9.38 | +24.32% |
Apr 2026 | $6.96 | $7.54 | +11.12% |
Mar 2026 | $7.14 | $6.79 | -5.96% |
Feb 2026 | $7.91 | $7.22 | -9.41% |
Jan 2026 | $8.62 | $7.97 | -5.23% |
Dec 2025 | $0.62 | $8.41 | +1,191.86% |
Nov 2025 | $0.75 | $0.65 | -13.08% |